Cas:23354-93-0 1,4-di(2-thienyl)-1,3-butadiene manufacturer & supplier

We serve Chemical Name:1,4-di(2-thienyl)-1,3-butadiene CAS:23354-93-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1,4-di(2-thienyl)-1,3-butadiene

Chemical Name:1,4-di(2-thienyl)-1,3-butadiene
CAS.NO:23354-93-0
Synonyms:1,4-di(2-thienyl)-1,3-butadiene
Molecular Formula:C12H10S2
Molecular Weight:218.33800
HS Code:2934999090

Physical and Chemical Properties:
Melting point:171ºC
Boiling point:385.8ºC at 760 mmHg
Density:1.225g/cm3
Index of Refraction:1.711
PSA:56.48000
Exact Mass:218.02200
LogP:4.53620

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1,4-di(2-thienyl)-1,3-butadiene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,4-di(2-thienyl)-1,3-butadiene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,4-di(2-thienyl)-1,3-butadiene Use and application,1,4-di(2-thienyl)-1,3-butadiene technical grade,usp/ep/jp grade.


Related News: The additional GMP labs will be able to develop and manufacture highly potent API (HPAPI) under GMP standards. The expanded labs and manufacturing facilities are expected to come online between 1Q22 and 3Q22. 2,2,2-trichloro-N-pyridin-3-ylacetamide manufacturers In the US, avalglucosidase alfa saw its PDUFA date pushed back by three months, from May 18 to Aug. 18, according to a Sanofi investor presentation in April. 2-Methyl-3-(1H-pyrazol-1-yl)propan-1-ol suppliers The additional GMP labs will be able to develop and manufacture highly potent API (HPAPI) under GMP standards. The expanded labs and manufacturing facilities are expected to come online between 1Q22 and 3Q22. 3-Cyclopropylaniline vendor & factory In the US, avalglucosidase alfa saw its PDUFA date pushed back by three months, from May 18 to Aug. 18, according to a Sanofi investor presentation in April.,The additional GMP labs will be able to develop and manufacture highly potent API (HPAPI) under GMP standards. The expanded labs and manufacturing facilities are expected to come online between 1Q22 and 3Q22.